- Report
- February 2026
- 250 Pages
Global
From €3987EUR$4,490USD£3,419GBP
- Report
- May 2026
- 182 Pages
Global
From €3996EUR$4,500USD£3,427GBP
- Report
- January 2026
- 181 Pages
Global
From €3996EUR$4,500USD£3,427GBP
- Drug Pipelines
- May 2026
- 80 Pages
Global
From €1776EUR$2,000USD£1,523GBP
- Report
- August 2026
- 180 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- July 2026
- 160 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- July 2026
- 120 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- May 2026
- 112 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- May 2026
- 114 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- May 2026
- 150 Pages
Global
From €2476EUR$2,789USD£2,124GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2476EUR$2,789USD£2,124GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2476EUR$2,789USD£2,124GBP
- Report
- July 2026
- 110 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- May 2026
- 146 Pages
Global
From €2663EUR$2,999USD£2,284GBP
€3551EUR$3,999USD£3,045GBP
- Report
- April 2026
- 142 Pages
Global
From €2663EUR$2,999USD£2,284GBP
€3551EUR$3,999USD£3,045GBP
- Report
- August 2026
- 382 Pages
Global
From €5194EUR$5,850USD£4,455GBP
- Report
- March 2026
- 200 Pages
Global
From €4435EUR$4,995USD£3,804GBP
- Report
- July 2026
- 160 Pages
Global
From €2948EUR$3,320USD£2,528GBP
€3685EUR$4,150USD£3,160GBP
- Report
- July 2026
- 160 Pages
Global
From €2948EUR$3,320USD£2,528GBP
€3685EUR$4,150USD£3,160GBP
- Report
- April 2026
- 160 Pages
Global
From €2948EUR$3,320USD£2,528GBP
€3685EUR$4,150USD£3,160GBP

The Macrolide Antibiotic market is a segment of the Infectious Diseases Drugs market. Macrolides are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. Macrolides are generally well-tolerated and have fewer side effects than other antibiotics. They are also effective against drug-resistant bacteria, making them an important tool in the fight against antibiotic resistance. Macrolides are available in both oral and intravenous formulations, and are often used in combination with other antibiotics.
The Macrolide Antibiotic market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more